4//SEC Filing
Hochman David P 4
Accession 0001104659-25-032334
CIK 0001814114other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 9:44 PM ET
Size
11.6 KB
Accession
0001104659-25-032334
Insider Transaction Report
Form 4
Hochman David P
DirectorSee Remarks
Transactions
- Award
Common Stock, par value $0.0001 per share ("Common Stock")
2025-04-04+98,333→ 579,498 total - Award
Stock Option (Right to Buy)
2025-04-04+147,500→ 147,500 totalExercise: $2.76Exp: 2035-04-04→ Common Stock (147,500 underlying)
Holdings
- 335,002(indirect: By Trust)
Common Stock
- 3,140(indirect: By Trust)
Common Stock
- 2,000(indirect: By Trust)
Common Stock
- 2,000(indirect: By Trust)
Common Stock
- 2,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Represents an award of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Common Stock. The RSUs vest over a three-year period as follows: (i) 33.33% of the shares will vest 24 months after April 4, 2025 (the "Issue Date"), (ii) 33.33% of the shares will vest 30 months after the Issue Date, and (iii) 33.34% of the shares will vest 36 months after the Issue Date, subject to the Reporting Person's continuous service through such dates.
- [F2]The stock options will vest as follows: (i) 36,875 of the stock options will vest on April 4, 2026 (the "Vesting Commencement Date") and (ii) the remaining 110,625 stock options will vest in equal installments every three months on the same day of the month as the Vesting Commencement Date, starting on July 4, 2026, subject to the Reporting Person's continuous service through such dates.
Documents
Issuer
Orchestra BioMed Holdings, Inc.
CIK 0001814114
Entity typeother
Related Parties
1- filerCIK 0001292834
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 9:44 PM ET
- Size
- 11.6 KB